SHARPIN and breast carcinoma: Supporting SIPL1's role in facilitating AKT activation in cervical cancer [20], we observed the co-existence of the SIPL1 protein with AKT activation in breast cancer (Fig 6A), although AKT activation was also detected in SIPL1- BC (Fig 6A).